To evaluate the association between having a household member with a cancer-related limitation (physical, mental, or emotional) and human papillomavirus (HPV) vaccine uptake among females aged 9 -17 years.
INTRODUCTION
Females aged 9 -17 years are prime candidates for the quadrivalent human papillomavirus (HPV) vaccine to prevent cervical cancer because the vaccine is most effective prior to sexual initiation. [1, 2] Preventive health behaviors in this age group are strongly influenced by family environment. [3] [4] [5] For example, the use of preventive health services is influenced by having a family member with limitations caused by a chronic illness. [6] Therefore, we evaluated whether females aged 9 -17 years who have a household member with a cancer-related limitation (physical, mental, or emotional) are more likely to initiate and complete the HPV vaccination.
METHODS

Data Source
We utilized data from the 2008 National Health Interview Survey (NHIS), which was the first NHIS to incorporate questions regarding HPV vaccine [7] . The NHIS is an annual in-person random household survey of the civilian non-institutionalized population of the United States. [8] Individual-level health information was ascertained using the Family Core survey for participants aged ≥18 years. For households with children, one child within the selected household was randomly sampled to complete the Sample Child Core survey by a knowledgeable adult proxy. All households with females aged 9 -17 years were eligible for inclusion in our analysis. We linked data for each child to the interviewed adult in her household and to relevant demographic and socioeconomic variables collected in the Household-Level, Family-Level, and PersonLevel files.
Variables
Our outcomes of interest included HPV vaccine initiation and series completion. 
Data analysis
We encoded a directed acyclic graph (DAG) [9] based on current evidence regarding factors that influence HPV vaccine uptake and their inter-relations to identify a minimal sufficient set of covariates for which to adjust in our analyses ( Figure 1 ).
Covariates that required adjustment (age, race/ethnicity, and socioeconomic status) to reduce confounding bias were identified using the back-door criterion [9] in a directed acyclic graph. Therefore, we adjusted for child's age, race/ethnicity, and SES in a multivariable regression model. Race/ethnicity was categorized as non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, Hispanic, and Other. SES was defined according to the education level of the person reported as the head of household (did not graduate from high school, high school graduate, some, college, college graduate or more) and family income as a percent of the federal poverty level adjusted for family size (<100%, 100%-199%, 200%-399%, ≥ 400%). [10] We compared the distribution of demographic and other characteristics between females who completed the full series of the HPV vaccine, females who initiated the HPV vaccine, and females who did not receive the HPV vaccine. Age was reported as medians and corresponding interquartile range (IQR), whereas categorical characteristics were reported as proportions. Furthermore, we used Firth's biasreducing penalized likelihood for logistic regression [11] in SAS 9.2 (SAS Institute, Cary, NC) to estimate prevalence odds ratios (ORs) and corresponding 95% profile penalized likelihood confidence intervals (CIs) for HPV vaccine uptake among young females who had a household member with a cancer-related limitation compared to young females who did not have a household member with a cancer-related limitation after adjusting for child's age, race/ethnicity, and SES. Penalized logistic regression was used to address issues with sparse data and separation [11] in our analyses.
RESULTS
Our study population consisted of 1,965 females aged 9 -17 years with a median age of 13 years (IQR: 11, 15). Ethnic minorities comprised nearly half of our study population (Whites=48.2%, Hispanics=26.4 Blacks=18.2%, Asians=6.2%). The highest proportion of females (36.4%) lived in a household where the head of household had at least a college degree. Furthermore, 62.8% of females lived in households with a family income ≥ 200% of the federal poverty level. The distribution of demographic characteristics by vaccine status is detailed in Table 1 .
The prevalence of HPV vaccine uptake initiation was 19.0% (95% CI: 17.0%, 21.1%) and the prevalence of HPV series completion (full 3 doses) was 7.8% (95% CI:
6.4%, 9.3%) in our study population. Females aged 9 -17 years who had a household member with a cancer-related limitation had 42% and 150% higher odds of initiating and completing the HPV vaccination, respectively, compared to those who did not have a household member with a cancer-related limitation (Initiation: OR=1.42, 95% CI: 0.26, 5.18; Completion: OR=2.50, 95% CI: 0.26, 11.58). The estimates for HPV vaccine initiation and completion are provided in Table 2 .
DISCUSSION
Our results suggest that females aged 9 -17 years in the United States who have a household member with a cancer-related limitation (physical, mental, or emotional) may be more likely to initiate and complete the HPV vaccination. However, our point estimates lack precision (evident by wide confidence intervals) because of limited prevalence of the exposure in our study population. Therefore, the durability of our findings is questionable without further analyses in a larger study population.
Although we did not specifically define family history of cancer as our exposure, our study advances this line of research by incorporating severity (limitation attributed to cancer) and proximity (living in the household) of cancer in the family as potential influences on HPV vaccine uptake. Furthermore, our study provides preliminary evidence that cancer within the family may be an important influence on actual HPV vaccine uptake and not just HPV vaccine acceptability, as reported in a pre-licensure study [12] .
Certain limitations of our analyses should be considered for appropriate interpretation of our results. Surveys with complex sampling methods, such as NHIS, require accounting for the complex survey design in the analyses to estimate parameters that can be generalized to the source population [13] (for NHIS, the source population is the United States population). However, our analyses required penalized methods to reduce bias created by sparse data and separation [11] . Unfortunately, penalized methods are currently unavailable for use with complex survey design analysis in SAS. We opted to compromise generalizability to the United States population for enhanced internal validity through bias reduction.
In summary, our results suggest that females aged 9 -17 years in the United
States who have a household member with a cancer-related limitation may be more likely to initiate and complete the HPV vaccination, but the durability of our findings are questionable because of few exposed individuals. Although preliminary, our findings may be useful for underscoring the important role of family environment on HPV vaccination uptake among young females, particularly for families that have experienced the debilitating potential of cancer. Given the promise of preventing cervical cancer through vaccination and the low prevalence of vaccine uptake observed in our study population, the identification of motivated subgroups may be useful for directing vaccine promotion efforts to less motivated subgroups that are eligible for the HPV vaccine.
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KEY MESSAGES
• The 2-year post-licensure prevalence of HPV vaccine initiation and completion is relatively low among young females aged 9 -17 years in our study population, which could have implications for vaccine promotion efforts.
• Familial factors may play an important role in HPV vaccine uptake.
• Identification of motivated subgroups may guide HPV vaccination efforts and facilitate efficient allocation of public health resources. 
